Cronos Group Inc (CRON) - Total Assets

Latest as of September 2025: CA$1.18 Billion CAD ≈ $852.44 Million USD

Based on the latest financial reports, Cronos Group Inc (CRON) holds total assets worth CA$1.18 Billion CAD (≈ $852.44 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Cronos Group Inc (CRON) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Cronos Group Inc - Total Assets Trend (2013–2024)

This chart illustrates how Cronos Group Inc's total assets have evolved over time, based on quarterly financial data. See CRON net assets for net asset value and shareholders' equity analysis.

Cronos Group Inc - Asset Composition Analysis

Current Asset Composition (December 2024)

Cronos Group Inc's total assets of CA$1.18 Billion consist of 80.3% current assets and 19.7% non-current assets.

Asset Category Amount (CAD) % of Total Assets
Cash & Equivalents CA$858.80 Million 73.6%
Accounts Receivable CA$29.77 Million 2.6%
Inventory CA$33.15 Million 2.8%
Property, Plant & Equipment CA$134.58 Million 11.5%
Intangible Assets CA$11.13 Million 1.0%
Goodwill CA$63.45 Million 5.4%

Asset Composition Trend (2013–2024)

This chart illustrates how Cronos Group Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Cronos Group Inc (CRON) market capitalisation.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Cronos Group Inc's current assets represent 80.3% of total assets in 2024, an increase from 2.9% in 2013.
  • Cash Position: Cash and equivalents constituted 73.6% of total assets in 2024, up from 0.6% in 2013.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, an increase from 0.0% in 2013.
  • Asset Diversification: The largest asset category is cash and equivalents at 73.6% of total assets.

Cronos Group Inc Competitors by Total Assets

Key competitors of Cronos Group Inc based on total assets are shown below.

Company Country Total Assets
Takeda Pharmaceutical Company Limited
F:TKDA
Germany €15.41 Trillion
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
China CN¥19.57 Billion
Beijing Sun Novo Pharmaceutical Research Co Ltd
SHG:688621
China CN¥2.30 Billion
Guizhou Xinbang Pharmaceutical Co Ltd
SHE:002390
China CN¥8.59 Billion
Guangdong Lifestrong Pharmacy Co. Ltd.
SHE:301111
China CN¥925.41 Million
Jw Pharmac
KO:001060
Korea ₩605.27 Billion
Kamada
TA:KMDA
Israel ILA377.21 Million
Samjin Pharm
KO:005500
Korea ₩449.14 Billion

Cronos Group Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 22.45 24.24 6.63
Quick Ratio 21.28 23.05 6.42
Cash Ratio 19.09 21.79 0.00
Working Capital CA$881.08 Million CA$919.61 Million CA$1.17 Billion

Cronos Group Inc - Advanced Valuation Insights

This section examines the relationship between Cronos Group Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.99
Latest Market Cap to Assets Ratio 0.94
Asset Growth Rate (YoY) 2.3%
Total Assets CA$1.17 Billion
Market Capitalization $1.09 Billion USD

Valuation Analysis

Near Book Valuation: The market values Cronos Group Inc's assets close to their book value (0.94x), suggesting investors view the company's assets at approximately fair value.

Positive Asset Growth: Cronos Group Inc's assets grew by 2.3% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Cronos Group Inc (2013–2024)

The table below shows the annual total assets of Cronos Group Inc from 2013 to 2024.

Year Total Assets Change
2024-12-31 CA$1.17 Billion
≈ $843.69 Million
+2.30%
2023-12-31 CA$1.14 Billion
≈ $824.72 Million
-6.01%
2022-12-31 CA$1.21 Billion
≈ $877.47 Million
-13.22%
2021-12-31 CA$1.40 Billion
≈ $1.01 Billion
-27.42%
2020-12-31 CA$1.93 Billion
≈ $1.39 Billion
-7.88%
2019-12-31 CA$2.09 Billion
≈ $1.51 Billion
+990.40%
2018-12-31 CA$191.71 Million
≈ $138.68 Million
+138.62%
2017-12-31 CA$80.34 Million
≈ $58.12 Million
+151.71%
2016-12-31 CA$31.92 Million
≈ $23.09 Million
+200.82%
2015-12-31 CA$10.61 Million
≈ $7.68 Million
+23.78%
2014-12-31 CA$8.57 Million
≈ $6.20 Million
+565.74%
2013-12-31 CA$1.29 Million
≈ $931.38K
--

About Cronos Group Inc

TO:CRON Canada Drug Manufacturers - Specialty & Generic
Market Cap
$1.09 Billion
CA$1.51 Billion CAD
Market Cap Rank
#8421 Global
#257 in Canada
Share Price
CA$3.95
Change (1 day)
-2.71%
52-Week Range
CA$2.83 - CA$4.49
All Time High
CA$31.77
About

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. The company is based in Stayner, Canada.